Marinomed Biotech AG

Major Shareholding Notification • Feb 22, 2019

Publication Date: 22.02.2019 11:42 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 22.2.2019

Overview

1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Event changing the breakdown of voting rights Other 3. Person subject to notification obligation

Acting in concert (Sec. 133 No. 7 BörseG 2018)

	________________
	Firstname _Name/Surname _City___ Country
	Mohammed___ Al_Sheikh__ ___ ______
	Abdulmohsen__ Al_Sheikh_ ___ _____
	Acropora Beteiligungs Wien	Österreich
	__ GmbH__ ___ __

1. Name of shareholder(s):

2. Date on which the threshold was crossed or reached: 20.2.2019

3. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on	23,27 %	0,00 %	23,27 %	1 430 772
which threshold
was crossed /
_reached __ __ __ __
Position of
previous	26,42 %
notification
(if_applicable) __ __ __ ___

Details 7. Notified details of the resulting situation:

A:Voting_rights_attached_to_shares______
			_Numberof_voting_rights _______%of_voting_rights____
	Direct	Indirect	Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
				___ 2018)__ _2018) __2018)_ 2018)___
				ATMARINOMED6_ _332_910 _______________ ________23,27% ____
				SUBTOTAL_A__ ____________332_910____________ ____________23,27%_______

______________________________________________________________________________

______________________________________________________________________________ |B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG | |2018__________________________________________________________________________|

			Number of voting
			rights that may
Type of			be	% of voting
instrument			Expiration Date Exercise Period acquired if the	rights
			instrument is
			___ ___ ___ __exercised_ _____
			___ ___ _SUBTOTAL_B.1 __ _____

	___________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018_____________
Type of	Expiration Exercise		Physical /		Number of		% of voting
instrument	Date	Period	Cash		voting rights		rights
	__ _ ___________ Settlement__ ____ ______
	__ _ __ SUBTOTALB.2_ __ _

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

			___________
				Financial/
		Directly	Shares held	other	Total of both
No.	Name		controlled directly (%) instruments		(%)
		by No.		held directly
			_ _ __ _ (%)_ _____
1	Abdulmohsen
			_ AlSheikh_ __ _ _ ____
2	Mohammed Al
			_ Sheikh __ ___ __ ____
	Acropora
3	Beteiligungs	1,2	23,27 %		23,27 %
			_ GmbH_ ___ ___ __ ____

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: Die Beteiligungsmeldung erfolgt aufgrund der Schwellenunterschreitung wegen der Kapitalerhöhung (Wandlung von ISIN AT00A1WD52) Wien am 22.2.2019

---

end of announcement euro adhoc

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:

stockmarkets: Wien language: English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service